Microglial Contributions to Huntington's Disease Pathogenesis

V2, Crosslink

🧫

Microglial Contributions to Huntington's Disease Pathogenesis

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-microgli

🧫 Experiment Protocol Validationproposed

SUMMARY

# Microglial Contributions to Huntington's Disease Pathogenesis ## Background and Rationale Microglial dysfunction represents a critical but understudied component of Huntington's disease pathogenesis, with these brain-resident immune cells exhibiting complex phenotypic transitions that can either exacerbate or ameliorate neurodegeneration depending on disease stage and environmental context. Unlike the relatively well-characterized role of mutant huntingtin in neurons, microglial contributions

METHODOLOGY NOTES

**Phase 1: Patient Recruitment and Sample Collection (Months 1-6)** • Recruit 120 participants: 40 HD patients (early stage, CAG 40-50 repeats), 40 HD patients (advanced stage, CAG >50 repeats), 40 age-matched controls • Collect CSF samples via lumbar puncture for cytokine analysis and microglial markers • Obtain blood samples for peripheral immune profiling and genetic confirmation • Perform comprehensive neurological assessment using UHDRS total motor score • Conduct MRI imaging with DTI and structural sequences **Phase 2: Post-mortem Tissue Analysis (Months 3-12)** • Obtain fresh-frozen brain tissue from 30 HD cases (15 early, 15 late stage) and 15 controls • Perform immunohistochemical staining for microglial markers: Iba1, CD68, TMEM119, P2RY12 • Quantify microglial morphology using 3D reconstructions in striatum, cortex, and hippocampus • Measure co-localization of activated microglia with huntingtin aggregates using proximity ligation assay • Analyze tissue cytokine levels via

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.908070Z'}
summary	# Microglial Contributions to Huntington's Disease Pathogenesis ## Background and Rationale Microglial dysfunction represents a critical but understudied component of Huntington's disease pathogenesis
entities	{'genes': ['HD'], 'diseases': ['Neuroinflammation']}
model_system	human
_schema_version	1
experiment_type	validation
primary_outcome	Validate Microglial Contributions to Huntington's Disease Pathogenesis
methodology_notes	Phase 1: Patient Recruitment and Sample Collection (Months 1-6) • Recruit 120 participants: 40 HD patients (early stage, CAG 40-50 repeats), 40 HD patients (advanced stage, CAG >50 repeats), 40 ag
replication_status	replicated
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.908076', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

357

Outgoing

324

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Microglial Contributions to Huntington's Disease Pathogenesis

derives from (16)

💬 Discussion